Stemline Therapeutics (STML) - NASDAQ
From other sites
Company Description
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering, acquiring, developing and commercializing proprietary therapeutics that target cancer stem cells. It currently developing two clinical stage products: SL-401 and SL-701, as well as a pipeline... More
Sector: Healthcare
Industry: Drug Related Products
Country: United States